#USA #San Francisco #AI-driven #HealthTech #MediKarma

MediKarma's Leadership Expansion: A Step Forward in Value-Based Healthcare

MediKarma, a cutting-edge platform focused on AI-driven healthcare solutions, has recently bolstered its executive team with the additions of Dr. Scott Howell and Angela Breton. Dr. Howell will serve as the Chief Clinical Officer (CCO) while Breton takes on the role of Chief Revenue Officer (CRO). This dual hire is expected to elevate MediKarma's position in the rapidly evolving healthcare landscape, particularly as the company aims to streamline its clinical pathways and market presence across diverse healthcare segments.

Dr. Scott Howell: Shaping Clinical Expertise

Dr. Scott Howell, an accomplished medical professional with a decorated record in both military service and healthcare management, brings a wealth of experience to MediKarma. His credentials include previous Chief Medical Officer roles within health plans and medical groups, where he was instrumental in refining clinical operations. In his new capacity as CCO, Dr. Howell will focus on enhancing MediKarma's clinical framework, specifically aiming to create tailored clinical pathways that enhance the user experience. With a board certification in three medical specialties and a rich military background, including a lengthy career in the Air Force Reserves, his leadership is expected to introduce significant advancements in clinical strategy.

In light of this appointment, Dr. Howell commented, "MediKarma has solved the foundational data problem in healthcare by creating a unified, actionable patient profile. My role is to translate that powerful data into clinical reality, designing pathways that allow providers to intervene earlier and manage risk more effectively. This opportunity to impact population health significantly is truly exciting."

Angela Breton: Driving Revenue Growth

Alongside Dr. Howell, Angela Breton joins MediKarma as CRO, tasked with spearheading the company's revenue generation efforts. With over 20 years of extensive experience in scaling healthcare technology ventures, Breton's past achievements include steering a tech-enabled radiology service to remarkable growth rates, and creating models that delivered shared savings of over $30 million. Her track record positions her as a strategic leader capable of guiding MediKarma through its upcoming phases of growth.

"We often overlook what transpires between medical appointments, yet that's where the biggest opportunities lie, both for patients and care providers. MediKarma illuminates these opportunities by consolidating data into actionable profiles that empower better decision-making," stated Breton. She aims to lead revenue strategy across pivotal sectors, including health plans and provider groups, facilitating MediKarma's transition to larger-scale implementation.

The Path Ahead

MediKarma's CEO, Kris Narayan, highlighted the critical nature of these appointments, stating, "With Dr. Howell's clinical rigor and Angie's expertise in building revenue engines, we now have the necessary leadership infrastructure for robust and responsible growth. Our ambitions to enhance patient care through innovative technology draws on their extensive backgrounds."

As MediKarma integrates its AI capabilities with personalized treatment plans, the company stands to redefine healthcare delivery by refining the complex interactions between data, technology, and patient engagement. This integrated approach aims not only to close care gaps but also to deliver measurable clinical outcomes that are fundamental to value-based care.

MediKarma's mission encapsulates a commitment to making healthcare more proactive, personalized, and ultimately, more effective. By aligning expert leadership with innovative technology, the company is poised to play a transformative role in the future of healthcare.

For additional information or media inquiries regarding this development, you can reach out to Nataliya Howard at 925.628.7424 or email [email protected].